Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2018-05-01
Reeks:Experimental Hematology & Oncology
Onderwerpen:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
Online toegang:http://link.springer.com/article/10.1186/s40164-018-0104-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items